BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #716Biotechnology
$17.08 +$0.17 (+0.98%)
Market open · Oct 1, 11:50 am ET · After hours $16.92 +0.06%
Open$16.82
Prev close$16.91
Day range$16.59 – $17.18
Volume2.66M
Market cap$13.62B
P/E (TTM)–
Dividend yield–

SMMT Stock News

Headlines matching Summit Therapeutics or the SMMT ticker, most recent first.

  • Jefferies Upgrades Summit Therapeutics(SMMT.US) to Buy Rating, Raises Target Price to $25Market news · 9 Sep 2026
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $43Market news · 30 Sep 2026
  • Clear Street Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $31Market news · 3 Sep 2026
  • H.C. Wainwright Maintains Summit Therapeutics(SMMT.US) With Hold RatingMarket news · 23 Sep 2026
  • Barclays Maintains Summit Therapeutics(SMMT.US) With Hold Rating, Maintains Target Price $18Market news · 21 Sep 2026
  • UBS Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $33Market news · 14 Sep 2026
  • Citi Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $40Market news · 14 Sep 2026
  • Goldman Sachs Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $41Market news · 14 Sep 2026
  • Wells Fargo Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $30Market news · 27 Aug 2026
  • Wolfe Research Initiates Summit Therapeutics(SMMT.US) With Hold RatingMarket news · 17 Aug 2026
  • Bernstein Maintains Summit Therapeutics(SMMT.US) With Sell Rating, Maintains Target Price $9.8Market news · 11 Aug 2026
  • Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $38Market news · 29 Jul 2026
  • TD Cowen Maintains Summit Therapeutics(SMMT.US) With Buy RatingMarket news · 28 Jul 2026
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $15 to $40Market news · 25 Jul 2026
  • A Quick Look at Today's Ratings for Summit Therapeutics(SMMT.US), With a Forecast Between $16 to $40Market news · 24 Jul 2026

Discussion

No comments yet — be the first to weigh in on SMMT.

Leave a comment

Scroll to Top